Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Sonoscape Medical Corp (300633 CH)
Watchlist
39
Analysis
Health Care
•
China
Sonoscape Medical Corp. manufactures medical equipment. The Company develops, produces, and sells ultrasound diagnostic systems, transducers, and other medical equipment products. Sonoscape Medical serves customers worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
11 Jan 2023 19:00
Presentation for Webinar: China Healthcare - Outlook and Opportunities in 2023
We're bullish on China healthcare in 2023 due to increasing household expenditure in “Long COVID” effect and the rebound of non-COVID medical...
Xinyao (Criss) Wang
Follow
659 Views
Share
bullish
•
Thematic (Sector/Industry)
•
19 Dec 2022 08:50
China Makes U-Turn on COVID Policy - Here Are the Direct Impacts and Investment Opportunities
China's U-turn on COVID policy will lead to rising infection/mortality rate.We analyzed the direct impact/investment opportunity. Under new...
Xinyao (Criss) Wang
Follow
684 Views
Share
bullish
•
Thematic (Sector/Industry)
•
08 Nov 2022 09:13
2023 High Conviction - China Healthcare: Recognize the Direction and Follow the Trend
The most obvious opportunity in China healthcare is import substitution,based on which companies in medical device sector are expected to have good...
Xinyao (Criss) Wang
Follow
678 Views
Share
bullish
•
Thematic (Sector/Industry)
•
18 Oct 2022 08:55
About the Recent Rebound in China Healthcare and the Future Direction (Updated Top Picks)
There's catalyst in medical device sector, leading to the recent rebound, but investors should exit in time before the truth is revealed. After the...
Xinyao (Criss) Wang
Follow
385 Views
Share
bearish
•
Thematic (Sector/Industry)
•
28 Aug 2022 09:15
China Healthcare Weekly (Aug.26) - Policy Trend, Aier Eye Hospital, Hospital Project Construction
Policy may shift from easing medical insurance pressure to improving people's livelihood. Low endogenous demand will affect company's valuation....
Xinyao (Criss) Wang
Follow
507 Views
Share
Previous
1
2
3
4
5
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x